From the Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA.
the Center for Advanced Intestinal Rehabilitation, Boston Children's Hospital and Harvard Medical School, Boston, MA.
J Pediatr Gastroenterol Nutr. 2023 Apr 1;76(4):468-474. doi: 10.1097/MPG.0000000000003718. Epub 2023 Jan 31.
There is a subset of intestinal failure patients with associated chronic intestinal inflammation resembling inflammatory bowel disease. This study aimed to evaluate factors associated with chronic intestinal inflammation in pediatric intestinal failure.
This was a single-center retrospective case-control study of children <18 years old with intestinal failure. Cases were defined by abnormal amounts of chronic intestinal inflammation on biopsies. Children with diversion colitis, eosinophilic colitis, or isolated anastomotic ulceration were excluded. Cases were matched 1:2 to intestinal failure controls based on sex, etiology of intestinal failure, and duration of intestinal failure. Multivariable conditional logistic regression was used to compare clinical factors between cases and controls, accounting for clustering within matched sets. A subgroup analysis was performed assessing factors associated with escalation of anti-inflammatory therapy.
Thirty cases were identified and matched to 60 controls. On univariate analysis, longer parenteral nutrition (PN) duration (1677 vs 834 days, P = 0.03), current PN use (33.3% vs 20.0%, P = 0.037), and culture-proven bacterial overgrowth (53.3% vs 31.7%, P = 0.05) were associated with chronic intestinal inflammation. On multivariable analysis, no variable reached statistical significance. On subgroup analysis, duration of intestinal failure, location of inflammation, and worst degree of inflammation on histology were associated with escalation of therapy.
PN dependence and intestinal dysbiosis are associated with chronic intestinal inflammation in children with intestinal failure. Severity of inflammation is associated with escalation of therapy. Further analysis is needed to assess these associations and the efficacy of treatments in this population.
有一部分肠衰竭患者伴有类似炎症性肠病的慢性肠道炎症。本研究旨在评估与儿科肠衰竭相关的慢性肠道炎症的相关因素。
这是一项单中心回顾性病例对照研究,纳入年龄<18 岁的肠衰竭儿童。病例定义为活检显示慢性肠道炎症程度异常。排除分流性结肠炎、嗜酸性粒细胞性结肠炎或孤立性吻合口溃疡的患儿。根据性别、肠衰竭病因和肠衰竭持续时间,将病例与肠衰竭对照进行 1:2 匹配。采用多变量条件逻辑回归比较病例和对照组的临床因素,同时考虑匹配组内的聚类。进行亚组分析,评估与抗炎治疗升级相关的因素。
共发现 30 例病例,并与 60 例对照相匹配。单因素分析显示,更长的肠外营养(PN)时间(1677 天 vs 834 天,P = 0.03)、当前使用 PN(33.3% vs 20.0%,P = 0.037)和培养证实的细菌过度生长(53.3% vs 31.7%,P = 0.05)与慢性肠道炎症相关。多变量分析中,没有变量具有统计学意义。亚组分析显示,肠衰竭持续时间、炎症部位和组织学上最严重的炎症程度与治疗升级相关。
PN 依赖和肠道菌群失调与儿童肠衰竭中的慢性肠道炎症相关。炎症严重程度与治疗升级相关。需要进一步分析以评估该人群中这些关联和治疗效果。